The effect of IL-1 on expression of the mineralization-related phenotype by chondrocytes was examined. In cultures of rabbit growth plate chondrocytes, IL-1 beta at 0.1 ng/ml caused 95% decreases in alkaline phosphatase activity, alkaline phosphatase mRNA levels, the incorporation of 45Ca into insoluble material, and the calcium content during the hypertrophic stage. These effects of IL-1 beta were dose-dependent and were observed in 24-48 h. Furthermore, IL-1 beta suppressed increase in cell size and the syntheses of 1,25-dihydroxyvitamin D3 receptor and type X collagen, other markers of hypertrophy, but had little effect on the synthesis of total protein including type II collagen. The inhibition of calcification was observed only when chondrocytes were exposed to IL-1 before the onset of calcification: IL-1 treatment from the mineralization stage had a marginal effect on 45Ca incorporation into insoluble material. These results suggest that IL-1 inhibits chondrocyte hypertrophy and the onset of calcification in ossifying cartilage. 
Introduction
IL-1, produced by monocytes and other cell types, induces various immune responses and serves as a mediator of inflammation ( 1, 2) . In addition, IL-I has a variety of metabolic, endocrinologic and neurological actions ( 1, 2).
IL-1 has been shown to inhibit proliferation of overtly differentiated chondrocytes (3) , although it stimulates proliferation of poorly differentiated chondrocytes (3) and fibroblasts (4) . It also suppresses the syntheses of type II collagen (5) and proteoglycans (6) by cultured chondrocytes in certain conditions. In addition, it induces the releases of prostaglandin E2, neutral metalloproteinases such as collagenase, and serine proteinases including plasminogen activator by synovial fibroblasts and chondrocytes (7) (8) (9) (10) (11) (12) (13) , causing breakdown ofthe car-yet known about the effect of IL-1 on the expression ofmineralization-related phenotypes by hypertrophying chondrocytes, because no good experimental model has been available.
Recently, we found that rabbit growth plate chondrocytes maintained as a pelleted mass in a centrifuge tube produce alkaline phosphatase (ALPase),' a marker of terminal differentiation ( 17) , at as a high level as that in growth plates in vivo (18) (19) (20) (21) . Furthermore, the extracellular matrix synthesized by these cells is calcified during the hypertrophic stage in the absence of added beta-glycerophosphate or inorganic phosphate ( 18 ) . This system of well-differentiated chondrocytes allowed us to examine the effects of IL-1 on chondrocyte hypertrophy and mineralization. Results showed that IL-1 beta at 0.01-0.1 ng/ml inhibited the increases in ALPase activity and mineralization in pelleted chondrocyte cultures. IL-1 also suppressed increase in cell size and the syntheses of ALPase mRNA, 1-alpha, 25-dihydroxyvitamin D3 ( l,25(OH)2vitamin D3) receptor and type X collagen in mass cultures on collagen gels. These results suggest that IL-1 inhibits the expressions of all terminal differentiation phenotypes by chondrocytes, and that it is a potent inhibitor of endochondral bone formation. These findings seem important for understanding the roles of IL-1 in fracture callus and arthritic cartilage.
Methods
Materials. Recombinant preparations of human IL-l alpha and beta were generous gifts from Dr. Y. Hirai (Otsuka Pharmaceutical Co., Tokushima, Japan). Indomethacin was purchased from Sigma Chemical Co. (St. Louis, MO) , type II collagen was from Koken Co. (Osaka, Japan), and a bovine parathyroid hormone fragment (PTH Cell culture. Chondrocytes were isolated from growth plates of the ribs of 4-wk-old male New Zealand White rabbits, as described previously (22, 23) . The cells (8 X 104) were suspended in 1 ml of Eagle's MEM with 10% fetal bovine serum, 50 Atg ascorbic acid, and 60 ,g kanamycin (medium A), transferred to a 15-ml plastic centrifuge tube (model 25319; Corning Glass Inc., Corning, NY), and centrifuged at 500 g (1,500 rpm in a clinical centrifuge) for 5 min (18) . The resulting cell pellet was incubated at 370C under 5% CO2 in air. Cultures were fed with fresh medium A (1 ml) 6 d after seeding, and thereafter, the medium was changed every other day. Ascorbic acid was added every other day during the whole culture period.
In other experiments, chondrocytes were seeded at high density (1.5 X I04 cells per 6-mm microwell or 3 X I05 cells per 50-mm dish) into tissue culture dishes or type II collagen-coated dishes, and maintained in 0.2 or 10 ml of Eagle's medium, alpha-modification (Flow Laboratories, McLean, VA) supplemented with 10% fetal bovine serum (Gibco, Grand Island, NY), 50 ,ug of ascorbic acid, 32 U of penicillin, and 40 gg of streptomycin per milliliter (medium B) or Dulbecco's medium, Iscove's modification (Flow Laboratories) supplemented with 10% fetal bovine serum, 50 Mg/ml of ascorbic acid, and antibiotics (medium C). The cultures were fed with fresh medium B or medium C 3 d after seeding, and thereafter, the medium was changed every other day.
Fibroblasts were grown out from minced muscle tissue of 4-wk-old male New Zealand White rabbits on 10-cm plastic culture dishes in medium A. They were harvested with trypsin, seeded at 1.5 X 104 cells per 6-mm collagen-coated well, and maintained in medium B.
Measurement ofALPase activity. ALPase activity was measured by a modification of the method of Bessey et al. (24) with para-nitrophenyl phosphate (pNP) as substrate. Cell pellets or cell matrix layers from cultures were homogenized with a glass homogenizer in 0.9% NaCl/0.2% Triton X-100 at 0C and centrifuged for 15 min at 12,000 g. The activity of the supernatant, which contained 95% of the total activity, was assayed in 0.5 M Tris-HCI buffer (pH 9.5) supplemented with 0.5 mM pNP and 0.5 mM MgCl2. The mixture was incubated at 370C for 10-30 min, and the reaction was stopped by addition of 0.25 vol of 1 M NaOH. Hydrolysis ofpNP was monitored as change in A4,0 in a spectrometer (Hitachi America Ltd., Brisbane, CA). para-Nitrophenol was used as a standard. 1 U of activity was defined as that catalyzing hydrolysis of 1 Mmol ofpNP/ug DNA. 30 min-'. ALPase activity associated with matrix vesicles and released into the medium was also determined. For this, the medium was centrifuged at 800 g for 10 min to remove cells and cell debris, and the matrix vesicles were recovered from the supernatant by filtration as described by Habuchi et al. (25) . Matrix vesicles recovered on filters (Millipore Corp., Bedford, MA) were solubilized with 2% Zwittergent (Calbiochem Corp., La Jolla, CA) in Tris-saline (0.15 M NaCl in 3.5 mM Tris-HCl, pH 7.4) (25) , and portions of the solution were assayed for ALPase activity.
Northern analysis. Growth plate chondrocytes were seeded (5 X 105 cells per 10-cm dish coated with type II collagen), and maintained in the presence of30 ml ofmedium B. Total RNA was extracted by the guanidine HCl method (26) . Samples of 15 ,g of total RNA were denatured in the presence of 2.2 M formaldehyde and 50% formamide at 65°C for 10 min, subjected to electrophoresis on 1% agarose gel containing 0.66 M formaldehyde, and transferred to a Nytran membrane (Schleicher & Schuell, Keene, NH) (27) . The Determination of total protein synthesis. Chondrocytes in 6-mm collagen-coated dishes were exposed to IL-l beta at 0 or 100 pg/ml 6 d after seeding in 0.1 ml of a 9:1 (vol/vol) mixture of methionine-free MEM and Dulbecco's modified Eagle's medium in the presence of
[35S] methionine (10 IuCi/ml) for 24 h. Total protein in cell layer fraction was subjected to SDS-polyacrylamide gel electrophoresis in 4-20% acrylamide gradient gel. After electrophoresis, the gels were processed for fluorography, and exposed to X-OMAT AR film (Eastman Kodak, Rochester, NY).
Determinations of '5Ca uptake and calcium. Pelleted cultures were exposed to 1 ml ofMEM supplemented with 45CaC12 (2 .Ci/culture) 3 h before the end ofincubation. Cultures on collagen-coated dishes were exposed to 0.1 ml of Eagle's medium, alpha-modification with 45CaC12 (1 MCi/culture) 3 h before the end of itcubation. Cell pellets or cell matrix layers were homogenized in 0.9% NaCl/0.2% Triton X-100 at 0°C, and then centrifuged for 15 min at 12,000 g. After separation of the supernatant, the precipitate was washed with 0.1 M CaCl2 in 0.05 M Tris-HCl, pH 7.4, at 20°C for 30 min to remove exchangeable 45Ca, and was then solubilized by incubation in 0.5 M HCI for 3 h at 200C (29) . Aliquots were used to determine "Ca radioactivity.
For determination ofthe calcium content, cell pellets or cell matrix layers were washed five times with PBS (calcium-and magnesiumfree) and then heated at 800°C for 10 h. The ash was dissolved in 6 M HC1 solution containing 1% lanthanum chloride, and its calcium content was determined with an atomic absorption spectrometer (model AA-640; Shimadzu, Kyoto, Japan). Staining of cell matrix layers with alizarin red was performed as described (30) .
Determinations ofDNA and uronic acid. Cell pellets or cell matrix layers were washed with PBS, and homogenized at 0°C in 1 ml of0.9% NaCl/0.2% Triton X-100. The homogenate (0.1-0.3 ml) was incubated at 37°C for 16 h with 1 mg/ml ofPronase E (Protease type XIV; Sigma Chemical Co.) in 3 ml of 0.05 M Tris-HCl buffer (pH 8.0) containing 0.9% NaCl, 1 mM CaCl2, and 0.2% Triton X-100. The resulting digest was used for determinations of DNA (31 ) and uronic acid (32) .
Results
Effects ofIL-I on induction ofALPase and calcification in pelleted chondrocyte cultures. Rabbit growth plate chondrocytes were seeded as a pelleted mass in a centrifuge tube, and maintained in medium A. In these cultures, the DNA content started to increase on day 3, and reached a plateau on day 10 ( 18-21 ) . ALPase activity started to increase after cessation of cell division on day 10, and reached a maximum on day 21 ( Fig. 1 A) (18) (19) (20) (21) . The addition of IL-1 beta on day 10 or 16 suppressed the increase in ALPase activity (Fig. 1 A) . This effect of IL-I beta on ALPase was reversible: after a shift from medium containing IL-I to IL-I-free medium, the ALPase activity promptly increased to a level similar to that in cultures not exposed to IL-I (Fig. 1 A) . The inhibitory effect of IL-I beta was detectable at 10 pg/ml and maximal at 100 pg/ml (Fig. 1 B) .
The incorporation of45Ca into insoluble material started to increase on day 12 and reached a maximum on day 16-18 ( Fig.  2 A) . The addition ofIL-I beta on day 10 or 16 suppressed this increase in the incorporation of 45Ca into insoluble material. The inhibition of calcification could be detected 2 d after addition of IL-1. The inhibition of 45Ca incorporation by IL-I beta was maximal at 100 pg/ml (Fig. 2 B) . Table I shows that IL-l beta suppressed the increase in the calcium content of pelleted cultures during the hypertrophic stage.
Effects ofIL-I on ALPase activity and ALPase mRNA levels in chondrocyte cultures on collagen-coated dishes. Rabbit growth plate chondrocytes were seeded at high density into collagen-coated dishes, and maintained in medium B. These chondrocyte cultures on collagen-coated dishes were used in all subsequent studies because their ALPase activity and calcification were 3 to 10 times those in pelleted cultures (33 In cultures on collagen-coated dishes, IL-I beta suppressed the increase in ALPase activity in the cell layer dose dependently (Fig. 3 A) : treatments with IL-I beta at 10, 100, and 1,000 pg/ml caused 30, 40, and 60% decreases, respectively, in ALPase activity in 24 h. This reduction in ALPase activity in the cell layer did not result from its release into the medium, because IL-1 did not increase the ALPase activity in the medium (Fig. 3 B) . IL-I alpha at 10-1,000 pg/ml also suppressed ALPase activity dose dependently (Fig. 3) .
Northern analysis showed that growth plate chondrocytes, but not permanent chondrocytes (not shown), express liver/ bone/kidney-type ALPase mRNA (Fig. 4) . The size (2.7 kb) of rabbit chondrocyte ALPase mRNA was the same as that of rat liver ALPase mRNA (28) . IL-1 beta at 100 pg/ml caused 50, 70, and 95% decreases in the ALPase mRNA content of growth plate chondrocytes after 24, 48, and 96 h, respectively (Fig. 4) . In similar conditions, IL-1 beta had little effect on the level of fibroblast growth factor receptor mRNA (flg transcript) (data not shown).
Effects of IL-I on the syntheses of 1,25 (OH)2vitamin D3 receptor and type X collagen. In chondrocyte cultures, binding of 1,25 (OH)2vitamin D3 increased during the hypertrophic stage (Fig. 5 A) (19, 33) . The affinity (kD, 0.49 nM) of the 1,25 (OH)2vitamin D3 receptor and the number of binding Cell Layer sites per cell ( 1 1,000) in hypertrophic chondrocytes in culture were similar to those (0.22-0.55 nM and 12,000, respectively) in the growth plate in vivo ( 19, 33) . Treatment with IL-I beta at 1-100 pg/ml decreased the binding of 1,25(OH)2vitamin D3 dose dependently (Fig. 5 B) .
Treatment with IL-1 beta at 10-100 pg/ml decreased the content of type X collagen, but had little effect on the type II collagen level (Fig. 6) . This (Fig. 7) . This effect of IL-I on chondrocyte size was detectable in 24 h (data not shown) and became prominent in 48 h (Fig. 7) .
In mass cultures on collagen-coated dishes, treatments with IL-I alpha and beta for 6 d suppressed the incorporation of 45Ca into insoluble material dose dependently, the concentrations of IL-I beta and alpha for half maximal inhibition being < 10 pg/ml (Fig. 8) . Accordingly, the calcium content ofmass cultures maintained with IL-i beta at 100 pg/ml was only 6% of that of IL-1-free cultures (Table II) .
In another series of studies, treatment of chondrocyte cultures with IL-i beta at 5 pg/mi from day 8 caused 60-70% decreases in the uronic acid content and ALPase activity on day 35. These inhibitions of proteoglycan accumulation and ALPase activity were reversible, when the cytokine was removed from the cultures from day 19. On the other hand, treatment with IL-I beta at 1 or 5 pg./ml during the early stage of hypertrophy (days 8-18) suppressed subsequent mineralization irreversibly, as judged by alizarin red staining (Fig. 9) .
Next, chondrocytes were exposed to IL-I beta at different times after seeding. The addition of IL-I beta from day 16 decreased 45Ca incorporation into insoluble material, whereas its addition from day 23 or 63 had a marginal effect (Table III) . Rabbit growth plate chondrocytes and fibroblasts were separately seeded at high density and maintained on type II collagen-coated dishes, as described in Methods. IL-I beta (100 pg/ml) was added from day 10. The contents of DNA and calcium were determined on day 35. Values are averages for duplicate cultures or those±SD for four cultures.
In these conditions, the addition ofthe cytokine from day 16 or 23 decreased the uronic acid (proteoglycan) content to 5-30% of the control levels (Table III) . Thus inhibition of calcification by IL-1 was dissociated from cytokine stimulation ofproteoglycan degradation. Previous studies have shown that PTH inhibits terminal differentiation ofchondrocytes (21 ) . Consistent with this finding, treatment with PTH for 6 d delayed subsequent increases in ALPase activity (Fig. 10 A) and 45Ca uptake (Fig. 10 B) . The addition of IL-I beta to cultures previously exposed to PTH from day 23 suppressed 45Ca uptake (Table III) , perhaps because of the delay in calcification. IL-1 B 5pg/ml Figure 9 . Effects of limited exposure to IL-I on the uronic acid content and ALPase activity in chondrocyte cultures. Cells were seeded and maintained as described in Methods. IL-I beta, at 0 (A), 1 The cyclooxygenase inhibitor indomethacin, at 10-6 M, has been shown to abolish IL-I beta-induced production ofprostaglandin E2 in human articular chondrocytes (13) . However, indomethacin, at 10-6 or 10-1 M, did not reverse the inhibitions by IL-I beta of ALPase and calcification in rabbit chondrocyte cultures (Table IV) .
Discussion
Effects ofIL-i on ALPase activity and calcification in the presence ofindomethacin. IL-lI is a strong stimulator of prostaglandin E2 production in synovial cells and chondrocytes (7) (8) (9) (10) (11) (12) (13) , and prostaglandins mediate some actions ofIL-1 (34, 35) . Early addition of IL-1 beta suppressed "5Ca incorporation into insoluble material during the initial mineralizing process, but its later addition had little effect. Later addition of PTH also had little effect on "5Ca incorporation into insoluble material (data not shown). Thus, the mineralization may become independent of the hormone and cytokines in a later phase. In any case, our results suggest that IL-l inhibits the onset ofcalcification by suppressing chondrocyte hypertrophy, although it may also affect calcification by causing breakdown of certain extracellular macromolecules. Previous studies have shown that infusion of IL-1 beta into normal mice (38) or production ofIL-1 beta by certain tumors (39) induces hypercalcemia by stimulating bone resorption. The present results suggest that this cytokine also affects endochondral bone formation by inhibiting chondrocyte hypertrophy and mineralization. At sites ofbone fracture, IL-1 stimulates resorption of nonfunctional bone fragments. IL-1 may impair fracture healing by inhibiting chondrocyte hypertrophy and mineralization, when it is formed in excess as a result of prolonged inflammation.
In arthritic cartilage, IL-1 causes reduction in matrix synthesis and enhances matrix degradation (40) . In a later stage, some chondrocyte clusters show increased syntheses of DNA and matrix: other chondrocytes become hypertrophic and induce formation of osteophytes to compromise dysfunction of the joint. Our results, taken together with previous observations (3, 5, 6) , suggest that IL-1 suppresses these reparative responses of arthritic chondrocytes.
Whether IL-1 plays a regulatory role in normal cartilage is not known. However, normal chondrocytes, as well as arthritic chondrocytes, produce IL-1 in culture (41-43). Furthermore, IL-1 gene expression is found in the hypertrophic zone of the growth plate in situ, whereas it is undetectable in elastic cartilage (44) . In preliminary studies, we found that the concentrations of IL-1 beta required for stimulation of syntheses of procollagenase and prostromelysin in cultures of hypertrophic chondrocytes are at least 30-fold lower than those in cultures of articular chondrocytes (Nakamura, S., Y. Okada and Y. Kato, unpublished observation). These observations suggest that IL-1 plays special roles in growth plate cartilage.
Previous studies have shown that IL-1 inhibits the syntheses of DNA (3), proteoglycan (5) , and collagen (6) by chondrocytes in certain culture conditions. However, IL-1 increased DNA synthesis or proteoglycan synthesis in other culture systems (45, 46) . On the other hand, IL-l consistently suppressed ALPase activity and mineralization in various culture systems with different batches ofrabbit and porcine chondrocytes (data not shown).
We conclude from the present study that IL-1 alpha and beta at low concentrations ( 1-10 pg/ml) inhibit chondrocyte hypertrophy and mineralization. Our results seem important for understanding the actions of IL-1 in fracture callus, arthritic cartilage, and growth plate cartilage.
